Lunch Program: PEERLESS RCT Results: Actionable Takeaways to Aid Interventional PE Risk Stratification and Practice
Sponsored by Inari Medical.
Discover the groundbreaking findings of the PEERLESS RCT, the first randomized trial in PE in the last decade. This program provides actionable takeaways to enhance interventional PE risk stratification and clinical decision-making. Explore how to evaluate patients for PE interventions through an engaging, case-based learning approach. Gain valuable insights into the safety, efficacy, and real-world application of FlowTriever in reshaping PE treatment protocols. Don’t miss this opportunity to refine your practice and improve outcomes for PE patients through data-driven strategies and expert-led discussions.